These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 203418)

  • 21. Bone histomorphometry in patients with chronic renal failure: effect of 1alpha-hydroxyvitamin D3.
    Melsen F; Nielsen HE; Christensen MS
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():39s-44s. PubMed ID: 606423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
    Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypophosphatemic vitamin D-resistant osteomalacia treated with 1 alpha- hydroxyvitamin D3 (Etalpha)].
    Lauridsen UB; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 1980 Apr; 142(18):1154-5. PubMed ID: 7404688
    [No Abstract]   [Full Text] [Related]  

  • 24. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
    Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure.
    Eastwood JB; Stamp TC; De Wardener HE; Bordier PJ; Arnaud CD
    Clin Sci Mol Med; 1977 May; 52(5):499-508. PubMed ID: 862343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia.
    Cohanim M; DeLuca HF; Yendt ER
    Johns Hopkins Med J; 1972 Aug; 131(2):118-32. PubMed ID: 4340527
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease.
    Pierides AM; Ellis HA; Simpson W; Cook D; Kerr DN
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():109s-116s. PubMed ID: 606409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROLE OF PHOSPHATE IN TREATMENT OF RENAL TUBULAR (HYPOPHOSPHATAEMIC) RICKETS AND OSTEOMALACIAS.
    ROSE GA
    Br Med J; 1964 Oct; 2(5413):857-61. PubMed ID: 14185638
    [No Abstract]   [Full Text] [Related]  

  • 31. Adult hypophosphatemic osteomalacia: report of two cases.
    Rico H; Gomez-Castresana F; Hernandez ER; Matute JA; Torrubiano J; Nunez-Torrón M
    Clin Rheumatol; 1985 Sep; 4(3):325-34. PubMed ID: 3840730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma vitamin D metabolites in a patient with sporadic hypophosphataemic osteomalacia (adult-onset type).
    Ulmann A; Bouchard P; Garabédian M; Bourdeau A; Witmer-Cournot G; Lacour B; Balsan S; Funck-Brentano JL
    Eur J Clin Invest; 1980 Oct; 10(5):369-72. PubMed ID: 6777170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3.
    Davies M; Mawer EB; Klass HJ; Lumb GA; Berry JL; Warnes TW
    Dig Dis Sci; 1983 Feb; 28(2):145-53. PubMed ID: 6297863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva.
    Stamp TC
    Curr Med Res Opin; 1981; 7(5):316-36. PubMed ID: 6894416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
    Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
    Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.
    Pierides AM; Ellis HA; Simpson W; Dewar JH; Ward MK; Kerr DN
    Lancet; 1976 May; 1(7969):1092-5. PubMed ID: 57505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.
    Reed JS; Meredith SC; Nemchausky BA; Rosenberg IH; Boyer JL
    Gastroenterology; 1980 Mar; 78(3):512-7. PubMed ID: 7351289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypophosphataemic osteomalacia due to de Toni-Debre-Fanconi syndrome in a 19-year old girl.
    Tsilchorozidou T; Yovos JG
    Hormones (Athens); 2005; 4(3):171-6. PubMed ID: 16613828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypophosphataemic vitamin-D resistant rickets may need phosphate supplements.
    Price HV; Woodhead JS
    Br Med J (Clin Res Ed); 1982 May; 284(6327):1442-3. PubMed ID: 6282378
    [No Abstract]   [Full Text] [Related]  

  • 40. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D.
    Marx SJ; Spiegel AM; Brown EM; Gardner DG; Downs RW; Attie M; Hamstra AJ; DeLuca HF
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1303-10. PubMed ID: 233695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.